Search results
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 3 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 5 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
...NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID-...
NewMediaWire via Yahoo Finance· 2 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...
CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial
Clinical Trials Arena via Yahoo Finance· 6 days agoThe double-blinded, randomised trial will compare CVXGA's efficacy, safety, and immunogenicity...
Biggest bombshells about Pentagon's anti-vax campaign from new report
Newsweek· 6 days agoThe United States military purportedly pushed an anti-vaccine disinformation campaign in the throes...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 6 days agoThey have tips on what you need to know this season. (Getty Images) Vera Vita via Getty Images It’s...
Moderna says next-generation COVID vaccine efficacy non-inferior to current shot
Reuters via Yahoo News· 7 days agoThe experimental vaccine, which met the main trial goal, was being tested in more than 11,000 people...
A Pentagon-approved bot attack attempted to thwart global COVID-19 vaccinations, report finds
Mashable· 4 days agoOne part of a larger, locally-targeted anti-vax campaign around the world, the propaganda efforts...
B.Riley lifts Vaxart shares target on BARDA award By Investing.com
Investing.com· 6 days agoThe award, which could total up to $453 million, is for conducting a Phase IIb study involving...
US government to fund up to $500 million for studies on oral, nasal COVID vaccines
Reuters via Yahoo News· 6 days agoNextGen, a $5 billion initiative led by the Biomedical Advanced Research and Development Authority (BARDA), to advance a pipeline of new, innovative vaccines and therapeutics ...